Prospective radiotherapy for patients with oropharyngeal carcinoma

Affiliations

¹ School of Arts, Wuhan University, Wuhan, 430072, Hubei, China. Electronic address: bellaciao@whu.edu.cn.
² Department of Oncology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.

Comment

Yue Wang et al. Lancet Oncol. 2017 Aug.

. 2017 Aug;18(8):e425.

doi: 10.1016/S1470-2045(17)30412-6. Epub 2017 Jul 26.

¹ School of Arts, Wuhan University, Wuhan, 430072, Hubei, China. Electronic address: bellaciao@whu.edu.cn.
² Department of Oncology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.

No abstract available

Comment in

Prospective radiotherapy for patients with oropharyngeal carcinoma - Authors' reply.
Chen AM, Beron PJ, Wong D, Rosove MH, Rao SD, Steinberg ML, Kupelian PA, Daly ME. Chen AM, et al. Lancet Oncol. 2017 Aug;18(8):e426. doi: 10.1016/S1470-2045(17)30534-X. Epub 2017 Jul 26. Lancet Oncol. 2017. PMID: 28759373 No abstract available.

Reduced-dose radiotherapy for human papillomavirus-associated squamous-cell carcinoma of the oropharynx: a single-arm, phase 2 study.
Chen AM, Felix C, Wang PC, Hsu S, Basehart V, Garst J, Beron P, Wong D, Rosove MH, Rao S, Melanson H, Kim E, Palmer D, Qi L, Kelly K, Steinberg ML, Kupelian PA, Daly ME. Chen AM, et al. Lancet Oncol. 2017 Jun;18(6):803-811. doi: 10.1016/S1470-2045(17)30246-2. Epub 2017 Apr 20. Lancet Oncol. 2017. PMID: 28434660 Free PMC article. Clinical Trial.